Cargando…
Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)
Autores principales: | Hadjigeorgiou, Georgios, Dardiotis, Efthimios, Tsivgoulis, Georgios, Doskas, Triantafyllos, Petrou, Damianos, Makris, Nikolaos, Vlaikidis, Nikolaos, Thomaidis, Thomas, Kyritsis, Athanasios, Fakas, Nikolaos, Treska, Xoulietta, Karageorgiou, Clementine, Sotirli, Stefania, Giannoulis, Christos, Papadimitriou, Dimitra, Mylonas, Ioannis, Kouremenos, Evaggelos, Vlachos, George S., Georgiopoulos, Dimitrios, Mademtzoglou, Despoina, Vikelis, Michalis, Zintzaras, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595477/ https://www.ncbi.nlm.nih.gov/pubmed/26440275 http://dx.doi.org/10.1371/journal.pone.0140308 |
Ejemplares similares
-
Observational Study Assessing Demographic, Economic and Clinical Factors Associated with Access and Utilization of Health Care Services of Patients with Multiple Sclerosis under Treatment with Interferon Beta-1b (EXTAVIA)
por: Hadjigeorgiou, Georgios, et al.
Publicado: (2014) -
A Prospective, Observational, Cohort Study to Assess the Efficacy and Safety of Prolonged-Release Fampridine in Cognition, Fatigue, Depression, and Quality of Life in Multiple Sclerosis Patients: The FAMILY Study
por: Mitsikostas, Dimos D., et al.
Publicado: (2021) -
The Effect of Disease Modifying Therapies on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Tsivgoulis, Georgios, et al.
Publicado: (2015) -
The Dimensionality of the Multidimensional Fatigue Inventory (MFI-20) Derived From Healthy Adults and Patient Subpopulations: A Challenge for Clinicians
por: Bakalidou, Daphne, et al.
Publicado: (2022) -
Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study
por: Deftereos, Spyros N., et al.
Publicado: (2018)